Mr. Market’s mood swings continued this past week, as global markets ended down for the second week in a row. The S&P 500 dropped 1.73%, the NASDAQ fell 1.25% and the MCSI Emerging Markets Index dropped 2.82%. The biggest gainer in your Alpha Investor Letter portfolio was Berkshire Hathaway (BRK-B), which rose 1.02% and hit […]
As painful as the current market sell-off may seem, it’s actually been much worse for most investors than the headlines would lead you to believe. After all, if you’re an investor focused on U.S. stocks, you’re probably feeling pretty good about yourself. Indeed, the Dow Jones Industrial Average ended May 4.08% higher, rising for six […]
Last week, the S&P 500 closed out the month of May with a drop of 1.14%. The MCSI Emerging Markets Index continued its recent decline, falling another 2.53%. Big gainers in your Bull Market Alert portfolio included Jazz Pharmaceuticals (JAZZ), which soared 6.62%, and Melco Crown Entertainment Limited (MPEL), which also jumped 2.5%. Last Wednesday, […]
It was a choppy and ultimately negative week in the stock market, with the S&P 500 down 0.55% and the MCSI Emerging Markets Index tumbling 2.16%. The big news, of course, was out of Japan, as the market took a massive dive of 7.6% last Thursday. As a result, you were stopped out of WisdomTree […]
I recommended last week that you buy options in two of your Ireland-related plays, Bank of Ireland (IRE) and Jazz Pharmaceuticals (JAZZ). Sure enough, both options are solidly up, even in the face of unsettled global stock markets. So with your October $10 IRE calls up 73.33% and September $65 JAZZ calls up 69.25%, sell […]
By both temperament and training, we Chartered Financial Analysts (CFAs) are a lot like accountants — reliable, ethical and well-grounded in the craft of investing. As basically geeky folks who have been investing an average of four years to earn the designation, we eagerly and self-servingly buy into the notion that the CFA is the […]